1. Home
  2. IVA vs NRGV Comparison

IVA vs NRGV Comparison

Compare IVA & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • NRGV
  • Stock Information
  • Founded
  • IVA 2011
  • NRGV 2017
  • Country
  • IVA France
  • NRGV United States
  • Employees
  • IVA N/A
  • NRGV N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • NRGV Industrial Machinery/Components
  • Sector
  • IVA Health Care
  • NRGV Miscellaneous
  • Exchange
  • IVA Nasdaq
  • NRGV Nasdaq
  • Market Cap
  • IVA 162.8M
  • NRGV 190.1M
  • IPO Year
  • IVA 2020
  • NRGV N/A
  • Fundamental
  • Price
  • IVA $3.90
  • NRGV $0.70
  • Analyst Decision
  • IVA Strong Buy
  • NRGV Buy
  • Analyst Count
  • IVA 4
  • NRGV 4
  • Target Price
  • IVA $10.50
  • NRGV $1.94
  • AVG Volume (30 Days)
  • IVA 23.7K
  • NRGV 2.2M
  • Earning Date
  • IVA 03-26-2025
  • NRGV 05-07-2025
  • Dividend Yield
  • IVA N/A
  • NRGV N/A
  • EPS Growth
  • IVA N/A
  • NRGV N/A
  • EPS
  • IVA N/A
  • NRGV N/A
  • Revenue
  • IVA $14,591,573.00
  • NRGV $46,199,000.00
  • Revenue This Year
  • IVA $15.38
  • NRGV $416.66
  • Revenue Next Year
  • IVA $24.22
  • NRGV $44.89
  • P/E Ratio
  • IVA N/A
  • NRGV N/A
  • Revenue Growth
  • IVA N/A
  • NRGV N/A
  • 52 Week Low
  • IVA $1.53
  • NRGV $0.60
  • 52 Week High
  • IVA $4.05
  • NRGV $2.70
  • Technical
  • Relative Strength Index (RSI)
  • IVA 69.86
  • NRGV 41.23
  • Support Level
  • IVA $3.69
  • NRGV $0.60
  • Resistance Level
  • IVA $4.05
  • NRGV $0.74
  • Average True Range (ATR)
  • IVA 0.25
  • NRGV 0.09
  • MACD
  • IVA 0.07
  • NRGV 0.02
  • Stochastic Oscillator
  • IVA 86.96
  • NRGV 40.17

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About NRGV Energy Vault Holdings Inc.

Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.

Share on Social Networks: